20160709 Annual Meeting SIG Sessions - Gynecological Pathology |
Gynecological Pathology Special Interest Group
Saturday July 9, 2000-2200
Towards molecular subclassification of endometrial carcinoma
Lien Hoang, Memorial Sloan Kettering Cancer Center
POLE mutant endometrial carcinomas: histopathological features and outcomes
Mary Kinloch, University of Saskatchewan
Dedifferentiated/Undifferentiated endometrial carcinoma: the molecular basis of an aggressive endometrial carcinoma variant distinct from serous or clear cell carcinoma
Chenghan Lee, University of Alberta
Objectives:
At the end of this session, participants will be able to:
1. Identify those results from The Cancer Genome Atlas that make it possible to now offer a genomic-based classification of endometrial carcinoma.
2. Describe the clinical and pathological features of endometrial cancers with POLE mutations.
3. List the molecular features that define the dedifferentiated/undifferentiated group of endometrial carcinomas.
1. Identify those results from The Cancer Genome Atlas that make it possible to now offer a genomic-based classification of endometrial carcinoma.
2. Describe the clinical and pathological features of endometrial cancers with POLE mutations.
3. List the molecular features that define the dedifferentiated/undifferentiated group of endometrial carcinomas.